ON-DEMAND WEBINARS

Join our solutions experts as they demonstrate how Castor ePRO can enhance your clinical trial by improving the patient experience and streamlining site operations.

The DECODE Obesity initiative aims to advance obesity drug development by generating evidence and optimizing digital health technologies to assess treatment benefits beyond weight loss.

Chief Scientific Officer Christine Guo, Ph.D., provides key insights into DHTs aimed at empowering study teams to strategically integrate these technologies into their clinical development initiatives.

An expert panel explores how the industry leverages digital innovation to manage immunotherapy risks and critical next steps toward deploying scalable, technology-driven CRS monitoring solutions.

ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

John Oncea Editor